|
Phase II randomized study of abiraterone acetate plus prednisone (AAP) added to ADT versus apalutamide alone (APA) versus AAP+APA in patients with advanced prostate cancer with noncastrate testosterone levels: (LACOG 0415). |
|
|
Honoraria - Astellas Pharma; Bayer Schering Pharma; BMS Brazil; Janssen Oncology; Merck Sharp & Dohme; Roche/Genentech |
Consulting or Advisory Role - Astellas Pharma; Bayer Schering Pharma; BMS Brazil; Janssen Oncology; Merck Sharp & Dohme; Roche/Genentech |
Research Funding - Janssen-Cilag (Inst) |
Travel, Accommodations, Expenses - Bayer Schering Pharma; Merck Sharp & Dohme |
|
|
Honoraria - AstraZeneca; Bristol-Myers Squibb; Novartis; Pfizer; Roche |
Consulting or Advisory Role - AstraZeneca; Ipsen; Merck Sharp & Dohme; Novartis; Pfizer; Roche |
|
|
No Relationships to Disclose |
|
|
|
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Janssen Oncology; Merck Sharp & Dohme; Pfizer; Roche |
Speakers' Bureau - Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Janssen Oncology; Merck Sharp & Dohme; Pfizer; Roche |
Research Funding - Janssen Oncology |
Travel, Accommodations, Expenses - Astellas Pharma; Bristol-Myers Squibb; Janssen-Cilag; Merck Sharp & Dohme; Roche |
|
|
|
Consulting or Advisory Role - Astellas Pharma; Pfizer |
Research Funding - Bristol-Myers Squibb; Janssen |
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Ipsen |
|
|
Consulting or Advisory Role - Janssen-Cilag |
|
|
|
|
|
|
|
|
Honoraria - Merck Sharp & Dohme; Roche/Genentech |
Consulting or Advisory Role - Merck Sharp & Dohme; Roche/Genentech |
Research Funding - AstraZeneca/MedImmune (Inst); Janssen-Cilag (Inst); Merck Serono (Inst); MSD Oncology (Inst); Roche/Genentech (Inst) |
Travel, Accommodations, Expenses - AstraZeneca; Pfizer |
|
|
Consulting or Advisory Role - Astellas Pharma; Bayer; Janssen |
Speakers' Bureau - Astellas Pharma; Bayer; Janssen |
Research Funding - Bayer; Janssen; Medivation; Myovant Sciences; Pfizer |
Travel, Accommodations, Expenses - Astellas Pharma; Bayer; Janssen; Roche |
|
|
No Relationships to Disclose |
|
David Queiroz Borges Muniz |
Speakers' Bureau - Janssen; Pfizer |
Research Funding - Janssen |
Travel, Accommodations, Expenses - Pfizer |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
Paulo Ricardo Santos Nunes Filho |
Employment - Grupo Oncoclinicas |
|
|
No Relationships to Disclose |